We are live on ! Find out more
VCIM

Velan Capital Investment Management Portfolio holdings

AUM $160M
1-Year Est. Return 517.12%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+517.12%
3 Year Est. Return
+2,524.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$108M
AUM Growth
-$21.1M
Cap. Flow
-$6.89M
Cap. Flow %
-6.4%
Top 10 Hldgs %
79.92%
Holding
31
New
4
Increased
4
Reduced
3
Closed
8

Top Buys

Rank Stock Value
1
RDUS
Radius Health, Inc.
RDUS
+$8.69M
2
ATRS
Antares Pharma, Inc.
ATRS
+$4.89M
3
OPTN
OptiNose
OPTN
+$4.76M
4
TELA icon
TELA Bio
TELA
+$1.83M
5
VTRS icon
Viatris
VTRS
+$1.32M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$11.3M
2
NMTR
9 Meters Biopharma
NMTR
+$4.24M
3
LITS
Lite Strategy Inc
LITS
+$2M
4
CRIS icon
Curis
CRIS
+$1.19M
5
NKGN
NKGen Biotech, Inc. Common Stock
NKGN
+$836K

Sector Composition

Rank Sector Weight
1 Healthcare 85.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LITS
26
Lite Strategy Inc
LITS
$31.4M
– –
-37,388
Closed -$2M
NVNO
27
enVVeno Medical
NVNO
$7.5M
– –
-2,128
Closed -$491K
XERS icon
28
CALL
Xeris Biopharma Holdings
XERS
$1.55B
– –
-446,500
Closed -$1.31M
ITCI
29
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-150,000
Closed -$7.85M
NKGN
30
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
– –
-86,506
Closed -$836K
NMTR
31
DELISTED
9 Meters Biopharma
NMTR
– –
-216,415
Closed -$4.24M
1
2

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
LCA
Legend Capital Advisors New York $160M AUM
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
RP
RIHO Partners Tucson, Arizona $159M AUM
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Velan Capital Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Velan Capital Investment Management held 31 positions worth $108M, down 16% from $129M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Velan Capital Investment Management withdrew a net $6.89M in Q1 2022, closing 8 positions and reducing 3 holdings. Its most notable exit was 9 Meters Biopharma, an estimated $4.24M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 89% a quarter earlier.

Against the trend, Velan Capital Investment Management opened a new position in Antares Pharma, Inc. worth $5.52M.

  • Velan Capital Investment Management's largest Q1 2022 buy was Antares Pharma, Inc.: 1,346,971 shares worth $5.52M.
  • Velan Capital Investment Management added most to Radius Health, Inc. in Q1 2022, an estimated $8.69M increase.
  • Velan Capital Investment Management's biggest Q1 2022 reduction was Lantheus, cutting an estimated $11.3M.
  • Velan Capital Investment Management fully exited 9 Meters Biopharma in Q1 2022, selling an estimated $4.24M.
  • Velan Capital Investment Management's ten largest holdings make up 80% of its $108M portfolio in Q1 2022.
  • Velan Capital Investment Management opened 4 new positions and closed 8 in Q1 2022.
  • Velan Capital Investment Management's portfolio value fell 16% quarter-over-quarter to $108M.

Based on Velan Capital Investment Management's 13F filing for Q1 2022, filed 16 May 2022.